[Form 4] EverQuote, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Jayme Mendal, who serves as CEO, President and a director of EverQuote, Inc. (ticker: EVER), reported sales of company Class A common stock on September 22, 2025 under a pre-established Rule 10b5-1 trading plan adopted on December 17, 2024. The Form 4 shows two sale entries: 100 shares sold at a weighted price of $23.76 and 14,260 shares sold at a weighted price reported as $24.54 (shares within that lot transacted between $24.02 and $24.88). After the reported transactions, the filing lists 498,420 shares of Class A common stock beneficially owned by Mendal. The Form 4 is signed by an attorney-in-fact, Jon Ayotte, dated September 24, 2025.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-planned and structured insider trading
- Transparent reporting of transaction dates, quantities, weighted price ranges and remaining beneficial ownership
Negative
- Material reduction in beneficial ownership from 512,680 to 498,420 shares following the reported sales
- Insider disposition of 14,360 Class A shares on September 22, 2025
Insights
TL;DR: Insider sales were executed under a pre-existing 10b5-1 plan, indicating rule-compliant liquidity rather than ad hoc disposition.
The signature of an attorney-in-fact and the explicit reference to a Rule 10b5-1 trading plan adopted on December 17, 2024, indicate these sales were pre-planned and reported in compliance with Section 16 requirements. The reduction in beneficial ownership from the earlier reported level to 498,420 shares is explicitly documented. For governance review, the filing provides clear transaction dates, quantities, and weighted price ranges, which supports transparency but does not explain the reporting person's intent beyond plan execution.
TL;DR: Sales totaling 14,360 shares were transacted at weighted prices around $24, within a 10b5-1 plan; the filing is routine and informational.
The Form 4 discloses two non-derivative sale transactions on September 22, 2025: 100 shares at $23.76 and 14,260 shares with a reported weighted price of $24.54 (individual trades ranged $24.02–$24.88). The remaining beneficial holding after these transactions is listed as 498,420 Class A shares. This is a standard insider reporting of disposition activity; the filing contains no additional operational or financial data that would alter valuation analysis.